Robuta

https://astx.com/2019-mdsf-development-of-an-oral-hypomethylating-agent-hma-as-a-fixed-dose-combination-fdc-of-decitabine-and-cda-inhibitor-cedazuridine/ 2019 MDSF: Development of an oral hypomethylating agent (HMA) as a fixed dose combination (FDC) of... fixed dose combination of an hypomethylating agent mdsf development https://dash.harvard.edu/entities/publication/73120379-3802-6bd4-e053-0100007fdf3b Validation of a post-hypomethylating agent failure prognostic model in myelodysplastic syndromes... of a hypomethylating agent prognostic model myelodysplastic syndromes validation